1478 related articles for article (PubMed ID: 28696824)
1. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
Stein-Zamir C; Israeli A
Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
[TBL] [Abstract][Full Text] [Related]
2. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel.
Stein-Zamir C; Israeli A
Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755293
[TBL] [Abstract][Full Text] [Related]
3. National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014.
Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Kolasa M
MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(33):889-96. PubMed ID: 26313470
[TBL] [Abstract][Full Text] [Related]
4. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2015.
Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Dietz V
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(39):1065-1071. PubMed ID: 27711036
[TBL] [Abstract][Full Text] [Related]
5. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project.
Tozzi AE; Piga S; Corchia C; Di Lallo D; Carnielli V; Chiandotto V; Fertz MC; Miniaci S; Rusconi F; Cuttini M
Vaccine; 2014 Feb; 32(7):793-9. PubMed ID: 24397902
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
7. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
Tielemans SMAJ; de Melker HE; Hahné SJM; Boef AGC; van der Klis FRM; Sanders EAM; van der Sande MAB; Knol MJ
BMJ; 2017 Aug; 358():j3862. PubMed ID: 28855159
[No Abstract] [Full Text] [Related]
8. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
Vesikari T; Karvonen A; Lindblad N; Korhonen T; Lommel P; Willems P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2010 Jun; 29(6):e47-56. PubMed ID: 20508478
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
10. Combination vaccine use and vaccination quality in a managed care population.
Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.
Zepp F; Behre U; Kindler K; Laakmann KH; Pankow-Culot H; Mannhardt-Laakmann W; Beckers F; Descamps D; Willems P
Eur J Pediatr; 2007 Aug; 166(8):857-64. PubMed ID: 17541639
[TBL] [Abstract][Full Text] [Related]
12. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
Sørup S; Benn CS; Poulsen A; Krause TG; Aaby P; Ravn H
JAMA; 2014 Feb; 311(8):826-35. PubMed ID: 24570246
[TBL] [Abstract][Full Text] [Related]
13. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
14. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA;
Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
[TBL] [Abstract][Full Text] [Related]
16. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.
Rieckmann A; Hærskjold A; Benn CS; Aaby P; Lange T; Sørup S
Int J Epidemiol; 2019 Dec; 48(6):2026-2038. PubMed ID: 31062020
[TBL] [Abstract][Full Text] [Related]
17. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
19. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
Madhi SA; Koen A; Cutland C; Groome M; Santos-Lima E
Pediatr Infect Dis J; 2013 Aug; 32(8):889-97. PubMed ID: 23538523
[TBL] [Abstract][Full Text] [Related]
20. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
Johns TL; Hutter GE
Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]